Observed versus modelled lifetime overall survival of targeted therapies and immunotherapies for advanced non-small cell lung cancer patients – A systematic review

Authors:

Abstract
No abstract available
Funding Information
  • Netherlands Organisation for Health Research and Development (846001002)
  • Dutch Cancer Society
  • Dutch health care insurance company Zilveren kruis Achmea

This publication has 55 references indexed in Scilit: